{"id":"https://openalex.org/W2914712464","doi":"https://doi.org/10.1182/blood-2018-99-118291","title":"Identification of Tipifarnib Sensitivity Biomarkers in T-Cell Tumor Cell Lines","display_name":"Identification of Tipifarnib Sensitivity Biomarkers in T-Cell Tumor Cell Lines","alternate_titles":[],"publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2914712464","doi":"https://doi.org/10.1182/blood-2018-99-118291","mag":"2914712464"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-118291","doi":"https://doi.org/10.1182/blood-2018-99-118291","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-118291","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2914712464"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015180886","display_name":"Ruth Alonso\u2010Alonso","orcid":"https://orcid.org/0000-0001-9503-7268","observed_orcids":["https://orcid.org/0000-0001-9503-7268"]},"institutions":[{"id":"https://openalex.org/I4210113075","display_name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla","ror":"https://ror.org/025gxrt12","country_code":"ES","type":"other","lineage":["https://openalex.org/I13134134","https://openalex.org/I4210113075"]},{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Ruth Alonso Alonso","raw_affiliation_strings":["Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain","Idival, Santander, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357"]},{"raw_affiliation_string":"Idival, Santander, Spain","institution_ids":["https://openalex.org/I4210113075"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077563777","display_name":"Rufino Mond\u00e9jar Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Rufino Mondejar Garc\u00eda","raw_affiliation_strings":["Anatom\u00eda Patol\u00f3gica, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anatom\u00eda Patol\u00f3gica, Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010316931","display_name":"Jos\u00e9 Pedro Vaqu\u00e9 D\u00edez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102893","display_name":"Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria","ror":"https://ror.org/01d963745","country_code":"ES","type":"facility","lineage":["https://openalex.org/I13134134","https://openalex.org/I134820265","https://openalex.org/I4210102893"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jose Pedro Vaqu\u00e9 D\u00edez","raw_affiliation_strings":["IBBTEC, Santander, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBBTEC, Santander, Spain","institution_ids":["https://openalex.org/I4210102893"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110696340","display_name":"Nuria Garc\u00eda D\u00edaz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102893","display_name":"Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria","ror":"https://ror.org/01d963745","country_code":"ES","type":"facility","lineage":["https://openalex.org/I13134134","https://openalex.org/I134820265","https://openalex.org/I4210102893"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nuria Garc\u00eda D\u00edaz","raw_affiliation_strings":["IBBTEC, Santander, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBBTEC, Santander, Spain","institution_ids":["https://openalex.org/I4210102893"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055561217","display_name":"Cristina P\u00e9rez Men\u00e9ndez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113075","display_name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla","ror":"https://ror.org/025gxrt12","country_code":"ES","type":"other","lineage":["https://openalex.org/I13134134","https://openalex.org/I4210113075"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Cristina P\u00e9rez Men\u00e9ndez","raw_affiliation_strings":["Idival, Santander, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Idival, Santander, Spain","institution_ids":["https://openalex.org/I4210113075"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027112745","display_name":"Francis J. Burrows","orcid":"https://orcid.org/0000-0003-0274-4911","observed_orcids":["https://orcid.org/0000-0003-0274-4911"]},"institutions":[{"id":"https://openalex.org/I4210153819","display_name":"Kura Oncology (United States)","ror":"https://ror.org/04wdp9936","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153819"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Francis Burrows","raw_affiliation_strings":["Kura Oncology, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kura Oncology, San Diego, CA","institution_ids":["https://openalex.org/I4210153819"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063754396","display_name":"Catherine Rose Scholz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153819","display_name":"Kura Oncology (United States)","ror":"https://ror.org/04wdp9936","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153819"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine Scholz","raw_affiliation_strings":["Kura Oncology, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kura Oncology, Cambridge, MA","institution_ids":["https://openalex.org/I4210153819"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021891844","display_name":"Antonio Gualberto","orcid":"https://orcid.org/0000-0002-6590-839X","observed_orcids":["https://orcid.org/0000-0002-6590-839X"]},"institutions":[{"id":"https://openalex.org/I4210153819","display_name":"Kura Oncology (United States)","ror":"https://ror.org/04wdp9936","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153819"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonio Gualberto","raw_affiliation_strings":["Kura Oncology, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kura Oncology, Cambridge, MA","institution_ids":["https://openalex.org/I4210153819"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069484088","display_name":"Miguel Angel Piris","orcid":"https://orcid.org/0000-0001-5839-3634","observed_orcids":["https://orcid.org/0000-0001-5839-3634"]},"institutions":[{"id":"https://openalex.org/I4210129357","display_name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz","ror":"https://ror.org/049nvyb15","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210129357"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Miguel A. Piris","raw_affiliation_strings":["Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain","institution_ids":["https://openalex.org/I4210129357"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5010316931","https://openalex.org/A5015180886","https://openalex.org/A5027112745","https://openalex.org/A5055561217","https://openalex.org/A5069484088","https://openalex.org/A5077563777"],"corresponding_institution_ids":["https://openalex.org/I4210102893","https://openalex.org/I4210113075","https://openalex.org/I4210129357","https://openalex.org/I4210153819"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"2851","last_page":"2851"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.39010000228881836,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.39010000228881836,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.32739999890327454,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.05730000138282776,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tipifarnib","display_name":"tipifarnib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/t-cell-leukemia","display_name":"T-cell leukemia","score":0.9319999814033508},{"id":"https://openalex.org/keywords/t-cell-lymphoma","display_name":"T-cell lymphoma","score":1.0},{"id":"https://openalex.org/keywords/drug-sensitivity-biomarkers","display_name":"drug sensitivity biomarkers","score":0.9240000247955322},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.9430000185966492},{"id":"https://openalex.org/keywords/ras-farnesylation","display_name":"Ras farnesylation","score":0.7609999775886536},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.5249999761581421},{"id":"https://openalex.org/keywords/nfat","display_name":"NFAT","score":0.5270000100135803},{"id":"https://openalex.org/keywords/nuclear-factor-kappab","display_name":"nuclear factor-kappaB","score":0.8140000104904175},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.9449999928474426},{"id":"https://openalex.org/keywords/differential-gene-expression","display_name":"differential gene expression","score":0.7480000257492065},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7820000052452087},{"id":"https://openalex.org/keywords/cell-cycle","display_name":"cell cycle","score":0.753000020980835},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.41600000858306885},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5736744403839111},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5435024499893188},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4737984538078308},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4732647240161896},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.47251471877098083},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.46885570883750916},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.45651933550834656},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.44720378518104553},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.4116196036338806},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.40633758902549744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33391010761260986},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3257695734500885},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2493215799331665},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1597026288509369},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09179738163948059},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08495089411735535},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-118291","doi":"https://doi.org/10.1182/blood-2018-99-118291","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-118291","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3017173383","https://openalex.org/W1986045177","https://openalex.org/W2622169789","https://openalex.org/W2073555925","https://openalex.org/W2101515818","https://openalex.org/W2906964479","https://openalex.org/W2984388117","https://openalex.org/W2886537999","https://openalex.org/W2980466166"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2914712464","counts_by_year":[],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-02-21T00:00:00"}
